These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16704292

  • 1. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
    Hess P, Grune B, Anderson DB, Aune T, Botana LM, Caricato P, van Egmond HP, Halder M, Hall S, Lawrence JF, Moffat C, Poletti R, Richmond J, Rossini GP, Seamer C, Vilageliu JS, ECVAM/DG SANCO Workshop.
    Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
    [No Abstract] [Full Text] [Related]

  • 2. The patchwork of toxicological research for pharmaceutical testing.
    von Aulock S.
    ALTEX; 2010 May; 27(1):1. PubMed ID: 20397314
    [No Abstract] [Full Text] [Related]

  • 3. The assessment of repeated dose toxicity in vitro: a proposed approach. The report and recommendations of ECVAM workshop 56.
    Prieto P, Baird AW, Blaauboer BJ, Castell Ripoll JV, Corvi R, Dekant W, Dietl P, Gennari A, Gribaldo L, Griffin JL, Hartung T, Heindel JJ, Hoet P, Jennings P, Marocchio L, Noraberg J, Pazos P, Westmoreland C, Wolf A, Wright J, Pfaller W.
    Altern Lab Anim; 2006 Jun; 34(3):315-41. PubMed ID: 16831063
    [No Abstract] [Full Text] [Related]

  • 4. Novel advanced in vitro methods for long-term toxicity testing: the report and recommendations of ECVAM workshop 45. European Centre for the Validation of Alternative Methods.
    Pfaller W, Balls M, Clothier R, Coecke S, Dierickx P, Ekwall B, Hanley BA, Hartung T, Prieto P, Ryan MP, Schmuck G, Sladowski D, Vericat JA, Wendel A, Wolf A, Zimmer J.
    Altern Lab Anim; 2001 Jun; 29(4):393-426. PubMed ID: 11506637
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.
    Coecke S, Ahr H, Blaauboer BJ, Bremer S, Casati S, Castell J, Combes R, Corvi R, Crespi CL, Cunningham ML, Elaut G, Eletti B, Freidig A, Gennari A, Ghersi-Egea JF, Guillouzo A, Hartung T, Hoet P, Ingelman-Sundberg M, Munn S, Janssens W, Ladstetter B, Leahy D, Long A, Meneguz A, Monshouwer M, Morath S, Nagelkerke F, Pelkonen O, Ponti J, Prieto P, Richert L, Sabbioni E, Schaack B, Steiling W, Testai E, Vericat JA, Worth A.
    Altern Lab Anim; 2006 Feb; 34(1):49-84. PubMed ID: 16522150
    [No Abstract] [Full Text] [Related]

  • 6. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52.
    Netzeva TI, Worth A, Aldenberg T, Benigni R, Cronin MT, Gramatica P, Jaworska JS, Kahn S, Klopman G, Marchant CA, Myatt G, Nikolova-Jeliazkova N, Patlewicz GY, Perkins R, Roberts D, Schultz T, Stanton DW, van de Sandt JJ, Tong W, Veith G, Yang C.
    Altern Lab Anim; 2005 Apr; 33(2):155-73. PubMed ID: 16180989
    [No Abstract] [Full Text] [Related]

  • 7. The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.
    Balls M, Amcoff P, Bremer S, Casati S, Coecke S, Clothier R, Combes R, Corvi R, Curren R, Eskes C, Fentem J, Gribaldo L, Halder M, Hartung T, Hoffmann S, Schectman L, Scott L, Spielmann H, Stokes W, Tice R, Wagner D, Zuang V, ECVAM.
    Altern Lab Anim; 2006 Dec; 34(6):603-20. PubMed ID: 17266393
    [No Abstract] [Full Text] [Related]

  • 8. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50.
    Gennari A, van den Berghe C, Casati S, Castell J, Clemedson C, Coecke S, Colombo A, Curren R, Dal Negro G, Goldberg A, Gosmore C, Hartung T, Langezaal I, Lessigiarska I, Maas W, Mangelsdorf I, Parchment R, Prieto P, Sintes JR, Ryan M, Schmuck G, Stitzel K, Stokes W, Vericat JA, Gribaldo L, ECVAM Workshop 50.
    Altern Lab Anim; 2004 Oct; 32(4):437-59. PubMed ID: 15651930
    [No Abstract] [Full Text] [Related]

  • 9. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshop.
    Pfuhler S, Kirkland D, Kasper P, Hayashi M, Vanparys P, Carmichael P, Dertinger S, Eastmond D, Elhajouji A, Krul C, Rothfuss A, Schoening G, Smith A, Speit G, Thomas C, van Benthem J, Corvi R.
    Mutat Res; 2009 Oct; 680(1-2):31-42. PubMed ID: 19765670
    [Abstract] [Full Text] [Related]

  • 10. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
    Chahoud I, Grote K.
    Toxicology; 2016 Jul 01; 363-364():46-7. PubMed ID: 27430607
    [No Abstract] [Full Text] [Related]

  • 11. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
    Spielmann H, Liebsch M.
    Toxicol In Vitro; 2001 Jul 01; 15(4-5):585-90. PubMed ID: 11566595
    [Abstract] [Full Text] [Related]

  • 12. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T, Pauwels M, Vinken M, Ceelen L, Rogiers V.
    Arch Toxicol; 2011 May 01; 85(5):365-6. PubMed ID: 21512801
    [No Abstract] [Full Text] [Related]

  • 13. Developing alternatives to systemic toxicity testing approaches.
    von Aulock S.
    ALTEX; 2012 May 01; 29(1):1. PubMed ID: 22408846
    [No Abstract] [Full Text] [Related]

  • 14. Summary: EU standards measurements and testing project PL95-3407. Development of a standardised in vitro methodology for hepatic and renal toxicity testing.
    Hartung T.
    Altern Lab Anim; 2001 May 01; 29(4):493-5. PubMed ID: 11565511
    [No Abstract] [Full Text] [Related]

  • 15. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
    Ceridono M, Tellner P, Bauer D, Barroso J, Alépée N, Corvi R, De Smedt A, Fellows MD, Gibbs NK, Heisler E, Jacobs A, Jirova D, Jones D, Kandárová H, Kasper P, Akunda JK, Krul C, Learn D, Liebsch M, Lynch AM, Muster W, Nakamura K, Nash JF, Pfannenbecker U, Phillips G, Robles C, Rogiers V, Van De Water F, Liminga UW, Vohr HW, Wattrelos O, Woods J, Zuang V, Kreysa J, Wilcox P.
    Regul Toxicol Pharmacol; 2012 Aug 01; 63(3):480-8. PubMed ID: 22687423
    [Abstract] [Full Text] [Related]

  • 16. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
    Rogiers V.
    Arch Toxicol; 2011 May 01; 85(5):363-4. PubMed ID: 21528384
    [No Abstract] [Full Text] [Related]

  • 17. Integrated decision-tree testing strategies for environmental toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C, Combes R, Cronin MT, Roberts DW, Garrod JF.
    Altern Lab Anim; 2008 Oct 01; 36 Suppl 1():29-42. PubMed ID: 19025330
    [Abstract] [Full Text] [Related]

  • 18. Validation is a key theme in this issue of ALTEX.
    von Aulock S.
    ALTEX; 2011 Oct 01; 28(1):1. PubMed ID: 21404727
    [No Abstract] [Full Text] [Related]

  • 19. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
    Combes RD.
    Altern Lab Anim; 2002 Dec 01; 30 Suppl 2():151-65. PubMed ID: 12513668
    [Abstract] [Full Text] [Related]

  • 20. Introduction to the EU REACH legislation.
    Grindon C, Combes R.
    Altern Lab Anim; 2008 Oct 01; 36 Suppl 1():1-6. PubMed ID: 19025328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.